The Legend Amr Diab and ONE Development Introduce DO Boutique Hotels, The First Musical Boutique Hotel Integrating AI, Music and Wellness
Setting a New Beat in the World’s Hospitality Sector
ONE Development, the UAE’s AI-driven boutique lifestyle property developer based in Abu Dhabi and Dubai has launched ONE/AD, an innovative endeavour set to disrupt the hospitality industry as the first musical themed boutique hotel integrating AI, music and wellness.Co-founded by ONE Development and the entertainment legend, superstarAmr Diab, DO Boutique Hotels is orchestrating a fusion of bold design, wellness, evocative music and AI.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250203540412/en/
The legend Amr Diab and Ali Al Gebely, Founder and Chairman of ONE Development unveil DO Boutique Hotels, the world’s first AI-driven musical boutique hotel, blending music, wellness, and technology to redefine hospitality. #LiveTheBeat (Photo: AETOSWire)
The global travel and tourism industry is experiencing robust growth, with destinations reporting record visitor numbers seeking innovative accommodation and improved quality of life. The launch of the new hotel chain by ONE/AD is seen as another step in support of both the UAE’s Tourism Strategy 2031 and those of the countries it is operating in, not only contributing to local and regional progress in the industry, but also boosting the economy by facilitating the attraction of increased investment.
“Our partnership with global legend Amr Diab is a bold step towards redefining hospitality industry,” said Ali Al Gebely, Founder and Chairman of ONE Development. “DO Boutique Hotels introduces a completely new disruptive hotel chain in the UAE, seamlessly blending music, design and AI to create spaces where luxury meets inspiration.”
Al Gebely added: "Music is a truly universal language and DO Boutique Hotels will redefine hospitality by crafting unique experiences inspired by music, enabling guests to connect with their creative rhythms. Building on its expertise in real estate and AI-driven concepts, ONE Development is once again setting new benchmarks in the industry, offering a harmonious blend of comfort, elegance, and unforgettable moments."
Amr Diab, founder of DO Boutique Hotels, said: “Music has always been my way of connecting with people; this vision now reaches into hospitality. DO Boutique Hotels create inspiring spaces where innovation, culture and wellness meet, offering today’s travellers exclusivity, creativity and meaningful connections.”
DO Boutique Hotels, under the slogan “Live the Beat,” offers an aspirational holistic lifestyle, transforming ordinary moments into extraordinary experiences. Each venue serves as a vibrant hub of creativity and connection, redefining hospitality and inspiring a renewed sense of living.
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20250203540412/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Celonis Appoints Daniel Brown as Chief Product Officer to Drive Platform Innovation and Growth3.2.2025 16:38:00 CET | Press release
Brown brings over 25 years of product strategy and development experience across multiple domains of enterprise software Celonis, the global leader in Process Mining and Process Intelligence, today announced the appointment of Daniel Brown as Chief Product Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250203013107/en/ Dan Brown joins Celonis as Chief Product Officer (Photo: Business Wire) “I am thrilled to join Celonis,” said Brown. “I’ve long admired its pioneering products, rapid innovation, and ability to deliver transformative results for customers and partners. What impresses me most is how the Celonis platform connects companies to their processes, teams to each other and AI to the business. I’m eager to contribute to this incredible journey and help shape the future of Process Intelligence.” “Dan brings a wealth of product strategy and leadership experience to Celonis,” said Alex Rinke, co-Founder and co-CEO
Michael Bowes Appointed Executive Vice President, Chief People Officer, The Estée Lauder Companies3.2.2025 16:10:00 CET | Press release
The Estée Lauder Companies Inc. (NYSE: EL) today announced that Michael Bowes has been appointed Executive Vice President, Chief People Officer, effective April 1, 2025, reporting directly to President and Chief Executive Officer, Stéphane de La Faverie. As the first company executive to hold the title of Chief People Officer, Michael will oversee all areas of Global Human Resources, including talent management, career development and organizational design, and, with a people-focused mindset, will drive the organization forward by focusing on continuous culture building. “Michael is a dynamic leader with a deep passion for people and culture,” said Stéphane. “His strategic vision, commitment to talent development, and ability to foster collaboration across our global organization make him the ideal leader to shape the future of our workforce. Michael’s promotion to EVP, Chief People Officer, reflects his exceptional track record and his unwavering commitment to making ELC a place where
Innovaderm Research, a Dual Focus CRO, Appoints Jeff Smith as New CEO3.2.2025 15:00:00 CET | Press release
Innovaderm Research, a leader in dermatological and rheumatological research, is proud to announce the appointment of Jeff Smith as the new CEO of the organization. This strategic change allows Innovaderm’s founder and former CEO, Dr. Robert Bissonnette, to fully dedicate himself to his role as Executive Chairman of Innovaderm, providing medical and scientific support to the CRO and its clients. Jeff brings nearly 30 years of experience in the pharmaceutical and CRO industry, most recently as CEO of another therapeutically focused CRO, where he has distinguished himself through his exceptional leadership, strategic vision, and ability to innovate. His expertise spans global operations, growth management, and fostering a collaborative and high-performing corporate culture. Jeff’s strengths in value creation, partner management, and CRO operations have consistently driven success in his previous roles. Jeff is well-equipped to lead Innovaderm into its next phase of growth and innovation.
ELIQUENT Life Sciences Announces: Rob Wojciechowski Named Chief Operations Officer3.2.2025 14:30:00 CET | Press release
ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the appointment of Rob Wojciechowski as Chief Operations Officer (COO). In this new role, Rob will oversee the company’s strategic initiatives across its regulatory, quality, and compliance practice areas, further positioning ELIQUENT to meet the growing global demand for integrated regulatory, quality, and safety solutions across diverse markets. “Rob’s expertise in building consulting practices and fostering client relationships aligns with ELIQUENT’s commitment to delivering innovative, high-quality solutions to meet the evolving needs of clients,” said Tim Dietlin, Chief Executive Officer, ELIQUENT Life Sciences. A seasoned life sciences executive and Non-Executive Director (NED) board member, Rob brings an extensive background in leadership, strategic consulting, and global business growth. As COO, Rob will work closely with the ELIQUENT leadership team to strengthen the fi
AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing3.2.2025 14:00:00 CET | Press release
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced the successful completion of an oversubscribed US$112 million Series C financing. This milestone funding round was co-led by SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis.Additional support came from existing investor Morningside, alongside new investors Tenmile, Brandon Capital, and others. Since its founding in June 2019, AdvanCell has grown from a belief in the potential of Targeted Alpha Therapy into a global organisation with 60 passionate team members, a 40,000-square-foot manufacturing facility, world-class pre-clinical infrastructure, a potentially best-in-class drug for prostate cancer that is in trials, and a deep and developing pipeline of assets. This investment will fuel AdvanCell’s ongoing efforts to expand its manufacturing capacity, accelerate the clinical development of its pipeline of radionuclide therapies, and advance its mission of de
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom